Safety and Efficacy of Natalizumab in Combination With Avonex in the Treatment of Multiple Sclerosis

This study has been completed.
Information provided by Biogen Idec

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Additional conditions recognized in this trial
			Multiple Sclerosis
			Multiple Sclerosis, Relapsing-Remitting
			Sclerosis
2		More general conditions related to this trial
			Autoimmune Diseases
			Autoimmune Diseases of the Nervous System
			Demyelinating Autoimmune Diseases, CNS
			Demyelinating Diseases
			Immune System Diseases
			Nervous System Diseases
			Pathologic Processes
3		Interventions listed in this trial
			Natalizumab
4		Sponsors listed in this trial
			Biogen Idec
			Elan Pharmaceuticals